Individualized treatment with aflibercept in age-related macular degeneration patients with early persistent retinal fluid

摘要

Age-related macular degeneration(AMD)is one of the leading causes of blindness among the elderly(1).Currently,there is no cure for the disease;however,intravitreal anti vascular endothelial growth factor(anti-VEGF)agents have significantly improved visual outcomes in patients with neovascular age-related macular degeneration(nAMD)